GSIOX
Price
$23.41
Change
+$0.45 (+1.96%)
Updated
Apr 23 closing price
Net Assets
113.54M
VEXRX
Price
$92.56
Change
+$1.44 (+1.58%)
Updated
Apr 23 closing price
Net Assets
19.79B
Ad is loading...

GSIOX vs VEXRX

Header iconGSIOX vs VEXRX Comparison
Open Charts GSIOX vs VEXRXBanner chart's image
Goldman Sachs Small Cap Gr Insghts Instl
Price$23.41
Change+$0.45 (+1.96%)
VolumeN/A
Net Assets113.54M
Vanguard Explorer Adm
Price$92.56
Change+$1.44 (+1.58%)
VolumeN/A
Net Assets19.79B
GSIOX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSIOX vs. VEXRX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSIOX is a Buy and VEXRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. GSIOX (114M). GSIOX pays higher dividends than VEXRX: GSIOX (0.89) vs VEXRX (0.56). GSIOX was incepted earlier than VEXRX: GSIOX (18 years) vs VEXRX (23 years). GSIOX (1.07) is less costly to investors than VEXRX (0.34). GSIOX is a more actively managed with annual turnover of: 166.00 vs. VEXRX (35.00). VEXRX has a lower initial minimum investment than GSIOX: VEXRX (50000) vs GSIOX (1000000). GSIOX annual gain was more profitable for investors over the last year : -0.63 vs. VEXRX (-12.82). VEXRX return over 5 years is better than : 15.80 vs. GSIOX (-32.04).
GSIOXVEXRXGSIOX / VEXRX
Total Expense Ratio0.850.34250%
Annual Report Gross Expense Ratio1.070.34315%
Fund Existence18 years23 years-
Gain YTD-16.204-14.722110%
Front LoadN/AN/A-
Min. Initial Investment1000000500002,000%
Min. Initial Investment IRAN/AN/A-
Net Assets114M19.8B1%
Annual Yield % from dividends0.890.56159%
Returns for 1 year-0.63-12.825%
Returns for 3 years13.62-9.40-145%
Returns for 5 years-32.0415.80-203%
Returns for 10 years-38.54-1.762,185%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XBI79.101.46
+1.88%
SPDR® S&P Biotech ETF
CHI9.780.17
+1.77%
Calamos Convertible Opportunities and Income Fund
SBIO28.020.45
+1.63%
ALPS Medical Breakthroughs ETF
BCDF28.540.12
+0.44%
Horizon Kinetics Blockchain Dev ETF
FEP41.67-0.06
-0.14%
First Trust Europe AlphaDEX® ETF